在红光疗法中作为近视控制的关键预测因子的轴向和胆道变化:来自机器学习模型的证据
Xiaoxue Hu1, Zixun Wang2, Rui Li3
1Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China.
Photodiagnosis and photodynamic therapy
|January 9, 2026
概括
重复的低水平红光疗法对儿童近视控制有希望. 机器学习模型准确地预测治疗结果,使用诸如轴长和胆道厚度变化等因素.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
- 数据科学数据科学数据科学
背景情况:
- 重复的低水平红光疗法 (RLRL) 是一种新的,非侵入性的近视控制方法.
- 在儿科近视症中RLRL疗效的预测因素需要进一步研究.
研究的目的:
- 开发和验证可解释的机器学习模型,用于预测儿童RLRL治疗的短期和长期结果.
- 为了确定RLRL治疗疗效的关键预测因素.
主要方法:
- 一项多中心队列研究,涉及538名儿科患者,随访时间至少为一年.
- 应用多种特征选择方法 (LASSO,Boruta等) 和七个机器学习算法.
- 使用SHAP和LIME进行模型解释性和性能评估 (AUC,精度,F1分数).
主要成果:
- XGBoost显示出最佳的预测性能 (AUC: 0.90-0.92).
- 确定了关键预测因素:年龄,基线轴长 (AL),前腔深 (ACD),RNFL厚度,AL变化 (ChangeAL) 和胸腔厚度变化 (ChangeChT).
- ChangeAL是主要的短期预测因素;ChangeChT对长期结果的影响最大. 年龄的增长和胆道结厚的增加显示出保护作用.
结论:
- 一个可解释的机器学习模型准确地预测了儿科近视的RLRL治疗结果.
- ChangeAL和ChangeChT是监测治疗反应的关键动态生物标志物.
- 研究结果支持针对近视管理的个性化临床决策.
相关概念视频
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Open Angle Glaucoma: Treatment
953
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
953


